WinterLight Labs: Hikma and Winterlight Labs PoC Collaboration

Hikma and Winterlight Labs collaborate to develop biomarkers for Schizophrenia patients in MENA Amman, Jordan ( AETOSWire) : Hikma Pharmaceuticals PLC ('Hikma'), the multinational pharmaceutical company, announces a collaboration agreement with Winterlight Labs, Inc., a Hikma Ventures portfolio company, to conduct a Proof-of-Concept (PoC) study to validate Winterlight Labs' speech-based biomarkers for schizophrenia patients in [...]